Out of the 200 dossiers that weren’t “killed”, I am pretty sure less than 100 are able to stay on the shelves. The other 100 still have live applications, but are paused awaiting more info. Don’t think they can sell product until they satisfy the agency’s request. I could be wrong in this, but my research was quick and done late at night, but that’s how I interpreted the info. Either way 200 or 100 companies left out of over 1000 applications (a couple hundred got thrown out as rubbish early on) has certainly cut down the competition. And as sticky has pointed out, validates the satipharm product. One of many positive announcements coming for cann over the next 12 months.
- Forums
- ASX - By Stock
- Ann: Satipharm CBD products get green light from UK FSA
Out of the 200 dossiers that weren’t “killed”, I am pretty sure...
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.12M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CAN (ASX) Chart |
Day chart unavailable
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online